Nuformix PLC (LON:NFX) shares rose 6.8% during mid-day trading on Friday . The stock traded as high as GBX 2.47 ($0.03) and last traded at GBX 2.35 ($0.03). Approximately 899,227 shares were traded during mid-day trading, a decline of 20% from the average daily volume of 1,130,000 shares. The stock had previously closed at GBX 2.20 ($0.03).
The company has a market cap of $11.06 million and a PE ratio of -4.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.55 and a current ratio of 1.55.
COPYRIGHT VIOLATION NOTICE: “Nuformix (NFX) Stock Price Up 6.8%” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://transcriptdaily.com/2019/03/24/nuformix-nfx-stock-price-up-6-8.html.
About Nuformix (LON:NFX)
Nuformix plc develops pharmaceutical products using its cocrystal technology in the United Kingdom. Its lead programs include NXP001, which is used for oncology supportive care; and NXP002 for use in the treatment of fibrosis. The company is also developing NXP003, which is under the pre-clinical stage for the treatment of anti-inflammatory diseases.
Further Reading: Trading Options- What is a Strangle?
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.